YONJIN VENTURE
Yonjin Venture is an investment firm specializing in investing in early and mid-stage life science companies. It focuses on the innovative technologies in therapeutics, diagnostics, and medical devices. The firm is a sub-organization of Yongjin Group and the sister firm of Yonghua Capital. The Cambridge, Massachusetts-based firm was established in 2018.
YONJIN VENTURE
Industry:
Health Diagnostics Medical Device Therapeutics Venture Capital
Founded:
2016-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
SPF Domain Not Resolving China Telecom DNS Pod
Similar Organizations
Allotrope Partners
Allotrope Partners is an investment firm specializing in early-stage companies in the carbon and clean energy sectors.
Biomark Capital
Biomark Capital provides venture funding and assistance to early, mid, and late-stage life science companies.
Boutique Venture Partners
Boutique Venture Partners specializes in early stage investments in healthcare and life sciences.
Broadview Ventures
Broadview Ventures invests in businesses that focus on the development of technology solutions in cardiovascular and neurovascular diseases.
Chiron Ventures
Chiron Ventures is an investment firm specializes in innovation and investment in medical health.
Desert Angels
Desert Angels is a network of investors looking for opportunities to invest in early-stage ventures.
Druid BioVentures
Druid BioVentures is a principal investment firm specializing in investments in novel drug with a focus on virtual companies.
DVI Equity Partners
DVI Equity Partners is specializes in micro-cap investments in start-up and early stage companies.
Inverness Graham Investments
Inverness Graham Investments is a private investment firm that acquires manufacturing, technology, and services companies.
Lilly Asia Ventures
Lilly Asian Ventures is an investment firm that invests in promising life science companies.
Lux Capital
Lux Capital is an investment firm investing in counter-conventional, early-stage science, and tech ventures.
NPX Capital
Global investment firm with a focus on early and growth stage companies
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-16 | Bluejay Therapeutics | Yonjin Venture investment in Series B - Bluejay Therapeutics | 41 M USD |
| 2022-08-15 | Regenacy Pharmaceuticals | Yonjin Venture investment in Series B - Regenacy Pharmaceuticals | 9.3 M USD |
| 2021-03-31 | OncoResponse | Yonjin Venture investment in Series C - OncoResponse | 40.6 M USD |
| 2021-02-01 | NanoCellect Biomedical | Yonjin Venture investment in Series C - NanoCellect Biomedical | 15 M USD |
| 2020-10-15 | Shenzhen Anteland Technology Co., Ltd. | Yonjin Venture investment in Series A - Shenzhen Anteland Technology Co., Ltd. | 25 M CNY |
| 2020-09-23 | Libra Therapeutics | Yonjin Venture investment in Series A - Libra Therapeutics | 29 M USD |
| 2020-06-16 | C4 Therapeutics | Yonjin Venture investment in Series B - C4 Therapeutics | N/A |
| 2020-06-08 | HistoSonics | Yonjin Venture investment in Series C - HistoSonics | 40 M USD |
| 2020-03-25 | Regenacy Pharmaceuticals | Yonjin Venture investment in Series A - Regenacy Pharmaceuticals | N/A |
| 2020-01-08 | EvolveImmune Therapeutics | Yonjin Venture investment in Venture Round - EvolveImmune Therapeutics | 17.55 M USD |